Original Research

Published on 21 Mar 2024

Methodological biases in observational hospital studies of COVID-19 treatment effectiveness: pitfalls and potential

in Regulatory Science

Oksana Martinuka
Derek Hazard
Hamid Reza Marateb
Marjan Mansourian
Miguel Ángel Mañanas
Sergio Romero
Manuel Rubio-Rivas
Martin Wolkewitz

Frontiers in Medicine

doi 10.3389/fmed.2024.1362192

2,254 views
2 citations

Editorial

Published on 18 Mar 2024

Editorial: Current priorities in health research agendas: tensions between public and commercial interests in prioritizing biomedical, social, and environmental aspects of health

in Regulatory Science

Mercedes García Carrillo
Marc-André Gagnon
Matías Blaustein

Frontiers in Medicine

doi 10.3389/fmed.2024.1391982

1,089 views
1 citation

Original Research

Published on 11 Mar 2024

Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimation

in Regulatory Science

Hiam Chemaitelly
Houssein H. Ayoub
Patrick Tang
Hadi M. Yassine
Asmaa A. Al Thani
Mohammad R. Hasan
Peter Coyle
Zaina Al-Kanaani
Einas Al-Kuwari
Andrew Jeremijenko

Frontiers in Medicine

doi 10.3389/fmed.2024.1363045

1,715 views
2 citations

Editorial

Published on 08 Mar 2024

Editorial: Women in science - regulatory science 2023

in Regulatory Science

Mette Due Theilade Thomsen
Lisbeth Ehlert Knudsen

Frontiers in Medicine

doi 10.3389/fmed.2024.1389438

898 views

Policy and Practice Reviews

Published on 06 Mar 2024

Patient listening on social media for patient-focused drug development: a synthesis of considerations from patients, industry and regulators

in Regulatory Science

Philipp Cimiano
Ben Collins
Maria Carmela De Vuono
Thierry Escudier
Jürgen Gottowik
Matthias Hartung
Mathias Leddin
Bikalpa Neupane
Raul Rodriguez-Esteban
Ana Lucia Schmidt

Frontiers in Medicine

doi 10.3389/fmed.2024.1274688

3,762 views
1 citation

Original Research

Published on 06 Mar 2024

Exploring the divergence in perspectives on clinical trial operations in South Korea during the COVID-19 pandemic: a comparison of a trial site and sponsors

in Regulatory Science

Young-Sang Kim
Anhye Kim
Yil-Seob Lee

Frontiers in Medicine

doi 10.3389/fmed.2024.1342184

2,226 views

Editorial

Published on 27 Feb 2024

Editorial: Reproductive medical care in minors: ethical and liability issues

in Regulatory Science

Mariano Cingolani
Vittoradolfo Tambone

Frontiers in Medicine

doi 10.3389/fmed.2024.1378211

1,016 views

Original Research

Published on 19 Feb 2024

Forecasting the potential impact of cell and gene therapies in France: projecting product launches and patients treated

in Regulatory Science

Ming Kei Lee
Sama Seyedmousavi
Sylvain Auvity
Bertrand Pourroy
Vincent Elleboode
Isabelle Kachaner
Christel Jansen
Herve Lilliu

Frontiers in Medicine

doi 10.3389/fmed.2024.1324602

2,783 views

Original Research

Published on 15 Feb 2024

Data from the Indian drug regulator and from Clinical Trials Registry-India does not always match

in Regulatory Science

Iqbal S. Bhalla
Adithi Gopadi Ravindranath
Ravi Vaswani
Gayatri Saberwal

Frontiers in Medicine

doi 10.3389/fmed.2024.1346208

1,608 views
1 citation

Original Research

Published on 15 Feb 2024

Assessment of the extent and monetary loss in the selected public hospitals in Jimma Zone, Ethiopia: expired medicine perspectives

in Regulatory Science

Habtamu Getahun
Sileshi Belew
Gemmechu Hasen
Yesuneh Tefera Mekasha
Sultan Suleman

Frontiers in Medicine

doi 10.3389/fmed.2024.1283070

2,214 views
2 citations

Original Research

Published on 08 Feb 2024

Predicting the submission frequency of periodic safety update reports: development and application of the EURD tool

in Regulatory Science

María Gordillo-Marañón
Gianmario Candore
Marta López-Fauqued
Katerina-Christina Deli
Loris Piccolo
Paolo Alcini
Tom Paternoster-Howe
Irene Rager
Robin Ruepp
Menno van der Elst

Frontiers in Medicine

doi 10.3389/fmed.2024.1299190

2,931 views

Perspective

Published on 31 Jan 2024

Unlocking the potential of big data and AI in medicine: insights from biobanking

in Regulatory Science

Kaya Akyüz
Mónica Cano Abadía
Melanie Goisauf
Michaela Th. Mayrhofer

Frontiers in Medicine

doi 10.3389/fmed.2024.1336588

2,904 views
2 citations

Original Research

Published on 24 Jan 2024

Prescription trend and lactic acidosis in patients prescribed metformin before and after the revision of package insert for allowing metformin administration to patients with moderately decreased kidney function based on real-world data from MID-NET® in Japan

in Regulatory Science

Takashi Waki
Yusuke Okada
Yuki Kinoshita
Kazuhiro Kajiyama
Chieko Ishiguro
Yuki Nakazato
Ryota Kimura
Harumi Maniwa
Naoya Horiuchi
Toyotaka Iguchi

Frontiers in Medicine

doi 10.3389/fmed.2023.1294696

1,905 views
1 citation

Perspective

Published on 23 Jan 2024

Industry influence on mental health research: depression as a case example

in Regulatory Science

Lisa Cosgrove
Elissa H. Patterson
Harold J. Bursztajn

Frontiers in Medicine

doi 10.3389/fmed.2023.1320304

5,343 views
1 citation

Perspective

Published on 17 Jan 2024

Drug repurposing for rare: progress and opportunities for the rare disease community

in Regulatory Science

Anneliene Hechtelt Jonker
Daniel O’Connor
Maria Cavaller-Bellaubi
Christine Fetro
Maria Gogou
Peter A. C. ’T Hoen
Martin de Kort
Heather Stone
Nivedita Valentine
Anna Maria Gerdina Pasmooij

Frontiers in Medicine

doi 10.3389/fmed.2024.1352803

9,092 views
7 citations

Opinion

Published on 11 Jan 2024

Navigating tensions between public and commercial interests: a case study of open source biosensors for detecting water contaminants in Argentina

in Regulatory Science

Alejandro D. Nadra

Frontiers in Medicine

doi 10.3389/fmed.2024.1268950

774 views

Navigation group

Articles

Methodological biases in observational hospital studies of COVID-19 treatment effectiveness: pitfalls and potential

Editorial: Current priorities in health research agendas: tensions between public and commercial interests in prioritizing biomedical, social, and environmental aspects of health

Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimation

Editorial: Women in science - regulatory science 2023

Patient listening on social media for patient-focused drug development: a synthesis of considerations from patients, industry and regulators

Exploring the divergence in perspectives on clinical trial operations in South Korea during the COVID-19 pandemic: a comparison of a trial site and sponsors

Editorial: Reproductive medical care in minors: ethical and liability issues

Forecasting the potential impact of cell and gene therapies in France: projecting product launches and patients treated

Data from the Indian drug regulator and from Clinical Trials Registry-India does not always match

Assessment of the extent and monetary loss in the selected public hospitals in Jimma Zone, Ethiopia: expired medicine perspectives

Predicting the submission frequency of periodic safety update reports: development and application of the EURD tool

Unlocking the potential of big data and AI in medicine: insights from biobanking

Prescription trend and lactic acidosis in patients prescribed metformin before and after the revision of package insert for allowing metformin administration to patients with moderately decreased kidney function based on real-world data from MID-NET® in Japan

Industry influence on mental health research: depression as a case example

Drug repurposing for rare: progress and opportunities for the rare disease community

Navigating tensions between public and commercial interests: a case study of open source biosensors for detecting water contaminants in Argentina